"The speed of enrollment lends itself to a majority of the 90 patients being in the moderate ARDS category (<200 mmHg)."
The entire basis of your argument has no substance. Please provide evidence for the above assumption.
Best to start a post with an educated set of statements and assumptions.
- Forums
- ASX - By Stock
- MSB
- COVID ARDS interim analysis
MSB
mesoblast limited
Add to My Watchlist
33.5%
!
$2.39

COVID ARDS interim analysis, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.39 |
Change
0.600(33.5%) |
Mkt cap ! $3.020B |
Open | High | Low | Value | Volume |
$1.90 | $2.41 | $1.90 | $37.08M | 16.74M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 16633 | $2.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.39 | 49129 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 83754 | 2.360 |
18 | 80186 | 2.350 |
14 | 60696 | 2.340 |
10 | 146958 | 2.330 |
9 | 361113 | 2.320 |
Price($) | Vol. | No. |
---|---|---|
2.370 | 20742 | 5 |
2.380 | 202520 | 19 |
2.390 | 143830 | 19 |
2.400 | 582104 | 33 |
2.410 | 108088 | 17 |
Last trade - 13.04pm 18/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |